Go to the Table Of Contents

Highlights for 2007 Treatment Episode Data Set (TEDS)


This report presents summary results from the Treatment Episode Data Set (TEDS) for 2007. The report provides information on the demographic and substance abuse characteristics of the 1.8 million annual admissions to treatment for abuse of alcohol and drugs in facilities that report to individual State administrative data systems [Table 1a].

This summary report is issued in advance of the full TEDS report for 1997-2007. It includes demographic data and all items from the TEDS Minimum Data Set. The full report also will include data from the Supplemental Data Set, State data, and State rates.

TEDS is an admission-based system, and TEDS admissions do not represent individuals. Thus, for example, an individual admitted to treatment twice within a calendar year would be count­ed as two admissions.

TEDS does not include all admissions to substance abuse treatment. It includes admissions to facilities that are licensed or certified by the State substance abuse agency to provide substance abuse treatment (or are administratively tracked by the agency for other reasons). In general, facilities reporting TEDS data are those that receive State alcohol and/or drug agency funds (including Federal Block Grant funds) for the provision of alcohol and/or drug treatment services.

Major Substances of Abuse



Other Opiates*



Methamphetamine/Amphetamine and Other Stimulants


Among all racial/ethnic groups except Hispanics of Puerto Rican origin, primary alcohol use (alone or in combination with other drugs) was the most frequently reported substance at treatment admission. However, the proportion reporting use of the next four most common substances (opiates, marijuana, cocaine, and stimulants) varied considerably by racial/ethnic group.

Type of Service

Medication-assisted Opioid Therapy

Source of Referral to Treatment

Employment Status

Educational Level

* These drugs include codeine, hydrocodone, hydro­morphone, meperidine, morphine, opium, oxycodone, pentazocine, propoxyphene, tramadol, and any other drug with morphine-like effects. Non-prescription use of methadone is not included.

To table of contents
To Table of Contents

This page was last updated on February 17, 2009.